FabiFlu more affordable than other drugs: Glenmark to DCGI
The company also sends its justifications and clarifications to allegations of false claims about FabiFlu’s use for COVID-19…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Covid-19 treatment
We are monitoring sale, supply of medicines for COVID-19 treatment: Haryana FDA
Haryana Medical Services Corporation (HMSC) has procured 400 vials of remdesivir and tocilizumab from Cipla to ensure availability…
DCGI approves Itolizumab for restricted emergency use in COVID-19 treatment
The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by an expert committee,…
Gilead begins testing inhalable form of remdesivir for COVID-19
The company said the trial will test the drug particularly in those cases where the disease has not progressed to require…
Cipla launches Cipremi, likely to price it Rs 4,000 per vial
It is looking to supply over 80,000 vials within the first month
Mylan to launch DESREM at Rs 4800 per vial
Mylan will manufacture remdesivir in India at its injectables facilities, which also make product for the US.
Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage
Many also allude to an emerging black market for remdesivir in the country through which the drug is being sold at exorbitant…
Mylan gets approval to make and market remdesivir
Jubilant, BDR and Dr Reddy's Labs have also awaiting permission from CDSCO to manufacture and market the drug in India and are…
Researchers identify drugs that may block cell to cell transmission of coronavirus
The scientists analysed all host and viral proteins that showed changes in an enzymatic process called phosphorylation after…
Researchers identify six potential drug targets for COVID-19
The tumour necrosis factor, granzyme B, heat shock protein 70, interleukin-18, interferon-gamma-inducible protein 10, and elastase…